Feb 10 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ:
OLIX AND LILLY ENTER GLOBAL LICENSING AGREEMENT FOR MASH AND OTHER CARDIOMETABOLIC INDICATIONS
OLIX PHARMACEUTICALS INC - COLLABORATION TO DEVELOP AND COMMERCIALIZE OLX75016 FOR MASH AND CARDIOMETABOLIC INDICATIONS
OLIX PHARMACEUTICALS INC - TO RECEIVE INITIAL PAYMENT FROM LILLY TO COMPLETE PHASE 1 TRIAL
Source text: ID:nBwkY77Ma
Further company coverage: 226950.KQ